Bin Zhou, PhD

Assistant Professor of Immunochemistry
Department of Chemistry
California Campus


Ph.D. (Molecular Biology), Shanghai Research Center of Biotechnology, 1999
B.S. (Biochemistry), Shanghai University of Science and Technology, 1990

Selected References

All Publications

Hwang, C. S., Ellis, B., Zhou, B. & Janda, K. D. Heat shock proteins: A dual carrier-adjuvant for an anti-drug vaccine against heroin. (2019). Bioorganic & Medicinal Chemistry, 27(1), 125-132.

Xue, S., Kallupi, M., Zhou, B., Smith, L. C., Miranda, P. O., George, O. & Janda, K. D. An enzymatic advance in nicotine cessation therapy. (2018). Chemical Communications, 54(14), 1686-1689.

Kallupi, M., Xue, S., Zhou, B., Janda, K. D. & George, O. An enzymatic approach reverses nicotine dependence, decreases compulsive-like intake, and prevents relapse. (2018). Science Advances, 4. PMCID: PMC6192681.

Hwang, C. S., Smith, L. C., Natori, Y., Ellis, B., Zhou, B. & Janda, K. D. Efficacious vaccine against heroin contaminated with fentanyl. (2018). ACS Chemical Neuroscience, 9(6), 1269-1275. PMCID: PMC6013375.

Hwang, C. S., Bremer, P. T., Wenthur, C. J., Ho, S. O., Chiang, S., Ellis, B., Zhou, B., Fuji, G. & Janda, K. D. Enhancing efficacy and stability of an antiheroin vaccine: examination of antinociception, opioid binding profile, and lethality. (2018). Molecular Pharmaceutics, 15(3), 1062-1072.

Hwang, C. S., Smith, L. C., Natori, Y., Ellis, B., Zhou, B. & Janda, K. D. Improved admixture vaccine of fentanyl and heroin hapten immunoconjugates: antinociceptive evaluation of fentanyl-contaminated heroin. (2018). ACS Omega, 3(9), 11537-11543. PMCID: PMC6166218.

Jacob, N. T., Miranda, P. O., Shirey, R. J., Gautam, R., Zhou, B., Izquierdo, M. E. D., Hixon, M. S., Hart, J. R., Ueno, L., Vogt, P. K. & Janda, K. D. Synthetic molecules for disruption of the MYC protein-protein interface. (2018). Bioorganic & Medicinal Chemistry, 26(14), 4234-4239.

Jacob, N. T., Anraku, K., Kimishima, A., Zhou, B., Collins, K. C., Lockner, J. W., Ellis, B. A. & Janda, K. D. A bioconjugate leveraging xenoreactive antibodies to alleviate cocaine-induced behavior. (2017). Chemical Communications, 53(58), 8156-8159.

Kimishima, A., Wenthur, C. J., Zhou, B. & Janda, K. D. An Advance in Prescription Opioid Vaccines: Overdose Mortality Reduction and Extraordinary Alteration of Drug Half-Life. (2017). ACS Chemical Biology, 12(1), 36-40.

Bremer, P. T., Schlosburg, J. E., Banks, M. L., Steele, F. F., Zhou, B., Poklis, J. L. & Janda, K. D. Development of a clinically viable heroin vaccine. (2017). Journal of the American Chemical Society, 139(25), 8601-8611.